Regulus Therapeutics SG&A Expense (TTM) Trends

Regulus Therapeutics Inc (RGLS)

1.785 -0.24 (-11.85%) USD | NASDAQ | Jun 28, 16:00

1.70 -0.08 (-4.76%) After-Hours: 06:16

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	10.30M
December 31, 2023	9.957M
September 30, 2023	9.639M
June 30, 2023	9.255M
March 31, 2023	9.383M
December 31, 2022	9.829M
September 30, 2022	10.16M
June 30, 2022	10.41M
March 31, 2022	10.43M
December 31, 2021	10.02M
September 30, 2021	9.548M
June 30, 2021	9.103M
March 31, 2021	8.869M
December 31, 2020	8.813M
September 30, 2020	9.098M
June 30, 2020	9.61M
March 31, 2020	10.21M
December 31, 2019	11.32M
September 30, 2019	11.70M
June 30, 2019	12.12M
March 31, 2019	12.62M
December 31, 2018	12.86M
September 30, 2018	13.37M
June 30, 2018	13.12M

Date	Value
March 31, 2018	16.82M
December 31, 2017	17.01M
September 30, 2017	18.53M
June 30, 2017	20.64M
March 31, 2017	17.25M
December 31, 2016	18.39M
September 30, 2016	19.04M
June 30, 2016	18.44M
March 31, 2016	20.59M
December 31, 2015	19.13M
September 30, 2015	16.98M
June 30, 2015	15.30M
March 31, 2015	12.44M
December 31, 2014	11.53M
September 30, 2014	10.14M
June 30, 2014	9.487M
March 31, 2014	8.256M
December 31, 2013	7.429M
September 30, 2013	7.479M
June 30, 2013	6.655M
March 31, 2013	5.916M
December 31, 2012	4.932M
September 30, 2012	3.771M
June 30, 2012	3.585M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

8.813M

Minimum

Dec 2020

11.70M

Maximum

Sep 2019

9.876M

Average

9.829M

Median

Dec 2022

SG&A Expense (TTM) Benchmarks